| 1 |
34490146 | Antibiotic Resistance Pattern of Extended Spectrum Beta Lactamase Producing Escherichia coli Isolated From Patients With Urinary Tract Infection in Morocco. | 2021 |
1 |
| 2 |
34666660 | [Investigation of Fosfomycin Susceptibility in Extended Spectrum Beta-Lactamase Producing Enteric Bacteria by Disk Diffusion, Automated System and Agar Dilütion Kit]. | 2021 Oct |
2 |
| 3 |
34804597 | Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin. | 2021 Nov |
2 |
| 4 |
32380640 | Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study. | 2020 May 5 |
2 |
| 5 |
32566057 | The Clinical Significance of High Antimicrobial Resistance in Community-Acquired Urinary Tract Infections. | 2020 |
1 |
| 6 |
32799271 | Sensitivity of extended spectrum of β-lactamase producing Escherichia coli and Klebsiella species to Fosfomycin. | 2020 Jul |
2 |
| 7 |
32840305 | Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase Escherichia coli urinary tract infection treatment. | 2020 Nov 16 |
2 |
| 8 |
33045444 | In vitro fosfomycin study on concordance of susceptibility testing methods against ESBL and carbapenem-resistant Enterobacteriaceae. | 2020 Dec |
4 |
| 9 |
30766796 | Chronic prostatitis caused by extended-spectrum β-lactamase-producing Escherichia coli managed using oral fosfomycin-A case report. | 2019 |
3 |
| 10 |
31258896 | Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae. | 2019 Jan-Dec |
3 |
| 11 |
32032026 | Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections. | 2019 Jan 31 |
3 |
| 12 |
32120467 | Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka | 2019 Dec 31 |
2 |
| 13 |
28992981 | Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: Evolution of antimicrobial resistance and treatment options. | 2018 Apr 13 |
1 |
| 14 |
29064348 | The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years. | 2018 Jun |
5 |
| 15 |
29924280 | [Sensitivity to Fosfomycin in Extended-spectrum Betalactamase-producing Escherichia coli]. | 2018 Jan-Mar |
3 |
| 16 |
28456703 | Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China. | 2017 Jul |
3 |
| 17 |
28457027 | Changing Antimicrobial Resistance Pattern of Isolates from an ICU Over a 3 Year period. | 2017 Feb |
1 |
| 18 |
26414659 | The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011. | 2016 Feb |
1 |
| 19 |
27013000 | Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature. | 2016 Apr |
1 |
| 20 |
27092771 | [Uropathogen pattern and antimicrobial susceptibility in positive urinary cultures isolates from paediatric patients]. | 2016 Jun |
1 |
| 21 |
26026972 | Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. | 2015 Jul |
1 |
| 22 |
26124169 | Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance. | 2015 Sep |
1 |
| 23 |
26349119 | [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria]. | 2015 Jan |
1 |
| 24 |
26816887 | Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance. | 2015 Dec |
3 |
| 25 |
25179392 | Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae. | 2014 Dec |
1 |
| 26 |
25492650 | [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations]. | 2014 Oct |
6 |
| 27 |
23742831 | Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey. | 2013 Nov |
3 |
| 28 |
24421836 | Determination of susceptibility to fosfomycin and tigecycline of Enterobacteriaceae, particularly Escherichia coli isolates, producing extended-spectrum β-lactamases from multiple regional Canadian hospitals. | 2013 Fall |
2 |
| 29 |
22893681 | Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. | 2012 Dec |
2 |
| 30 |
23198454 | In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon. | 2012 Jul-Sep |
7 |
| 31 |
20129148 | Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. | 2010 Jan |
4 |
| 32 |
20851815 | Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. | 2010 Nov |
8 |
| 33 |
19308743 | [In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin]. | 2009 Mar |
3 |
| 34 |
18154548 | Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. | 2008 Jan |
3 |
| 35 |
18423165 | [Etiology of community-acquired lower urinary infections and antimicrobial resistance of Escherichia coli: a national surveillance study]. | 2008 Apr 12 |
1 |
| 36 |
19255989 | In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. | 2008 Oct |
3 |
| 37 |
16377714 | In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures. | 2006 Jan |
3 |
| 38 |
17169640 | Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. | 2006 Dec |
1 |
| 39 |
17194386 | [Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae]. | 2006 Dec |
2 |